Liver reaction in connection with oral contraceptive steroids.
D000293:Adolescent; D000328:Adult; D000469:Alkaline Phosphatase / Q000097:blood; D000568:Amenorrhea / Q000139:chemically induced; D001663:Bilirubin / Q000097:blood; D050260:Carbohydrate Metabolism; D002986:Clinical Trials as Topic; D003276:Contraceptives, Oral / Q000009:adverse effects*; D004997:Ethinyl Estradiol / Q000009:adverse effects; D005260:Female; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D007565:Jaundice / Q000139:chemically induced*; D007770:L-Lactate Dehydrogenase / Q000097:blood; D050356:Lipid Metabolism; D008099:Liver / Q000187:drug effects*; D008234:Lynestrenol / Q000009:adverse effects; D008656:Mestranol / Q000009:adverse effects; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced; D009641:Norethynodrel / Q000009:adverse effects; D009765:Obesity / Q000139:chemically induced; D009954:Ornithine Carbamoyltransferase / Q000097:blood; D011506:Proteins / Q000378:metabolism; D011537:Pruritus / Q000139:chemically induced; D013924:Thrombophlebitis / Q000139:chemically induced
D003276:Contraceptives, Oral; D011506:Proteins; D004997:Ethinyl Estradiol; D009641:Norethynodrel; D008656:Mestranol; D007770:L-Lactate Dehydrogenase; D009954:Ornithine Carbamoyltransferase; D000469:Alkaline Phosphatase; D008234:Lynestrenol; D001663:Bilirubin